ASHP Policy Position 2018
SAFE USE OF TRANSDERMAL SYSTEM PATCHES
To encourage hospitals and health systems to implement policies and procedures to ensure safe use of transdermal system patches; further,
To advocate for enhanced patient and consumer education and product safety requirements for transdermal system patches; further,
To encourage manufacturers of transdermal system patches to collaborate with pharmacists and other stakeholders to identify and implement packaging, labeling, and formulation changes that prevent accidental exposure and facilitate safe disposal.
This policy position supersedes ASHP policy position 1404.
Rationale
There have been many reports of errors associated with and abuse or misuse of transdermal system patches. Pharmacists are in a unique position to improve the safe use of these products by encouraging implementation of best practices such as electronic health record builds; regular nursing checks for transdermal patches; and policies for ordering, handling, and disposal of these products. Better patient and consumer education specific to this unique dosage form, especially for outpatient use, is also an important component of safe use. Manufacturers could also take additional steps to prevent misuse of these products by collaborating with pharmacists and other stakeholders to identify and implement packaging, labeling, and formulation changes that would facilitate safe disposal and prevent accidental exposure.